As Part of Europe's leading Injectable conference series, the 5th annual
Injectable Drug Delivery conference will assess innovations in drug product formulation and biologics, new technologies in device design, along with the latest regulatory considerations for optimal drug delivery.
With increasing demand for vaccines, insulin, and many other modern medicines administered via the injectable route, there is significant growth projected in the biologics market, particularly the
injectable drug delivery and prefilled syringe market which is expected to rise at a compound annual growth rate of 12.9% reaching £915 billion by 2027. It is due to this rising demand and increased growth that the industry must come together to discuss and critically evaluate the next generation of
injectable drug delivery.
At this year's event we will highlight the most recent innovations within the industry, with regard to injectable device design and the formulation challenges of long-lasting, highly viscous and high-volume drug delivery. In silico modelling will be addressed as we continue to see a move towards AI utilisation, alongside key CMC concerns and usability of injectable devices in digital health. The conference will also highlight the significance of sustainability within the industry, whilst providing regulatory insight on the changes that have occurred and are forecast in the coming years.
Benefits of Attending
- Explore the latest trends within the Injectable drug delivery field, with new insights into in-silico modelling
- Expand on current knowledge of device design, with special considerations for primary and secondary packaging
- Examine injectable drug formulation strategies, including novel formulation methodologies
- Learn how to advance the injectable drug delivery landscape through a review of current regulatory compliance
- Realise how Chemical Manufacturing and Control can further expand the industry through digitalisation strategies
Who should attend
Executives, Directors, VPs, Heads, Principals, Managers, Scientists, Researchers of:
- Autoinjectors
- Wearables
- Device Engineering
- Human Factors
- CMC
- Injectables
- Sterile Manufacturing
- Packaging
- Regulatory Affairs
Featured Speakers
- Alper Hulusi, Head of Medical Devices Market Insights, Harvey Medical
- Amber Witteman, Founder - Managing Director, EPiWatch
- Annie Zavadil, Device Project Leader, Novartis
- Arabe Ahmed, Medicinal Technical Specialist, BSI
- Blake Green, Director Regulatory Affairs, Amgen Ltd
- Caroline Zakrzewski, Senior Engineer, AstraZeneca
- Caroline Prisk, Head of Regulatory Affairs, Victrex Plc
- Cedric Gysel, Health Care Solutions Manager, Johnson & Johnson
- Fatima Bennai-Sanfourche, Senior Director of QA & RA Compliance for Medical Devices and eHealth, Bayer AG
- Jeanne Greathouse, Global Director Healthcare, BSI Group
- Julia Frese, Director, TUV SUD Japan Ltd.
- Louise Place, Director, Devices Global CMC Regulatory Affairs, GSK
- Mark Milton-Edwards, Head of Health Solutions, Teva UK Ltd
- Shannon Clark, CEO, UserWise
- Thomas Wejs Moeller, Director Global Regulatory Affairs - Device, Novo Nordisk
- Tiffany McIntire, Principal Human Factors Engineer, Roche
- Vasco Filipe, Head Drug Product Development of Biologics, Sanofi
Please fill in your name and email to receive the Conference Agenda of this event.
Venue
Copthorne Tara Hotel
Scarsdale Pl, Kensington, W8 5SY
London, UK
To book your hotel room with our preferential group rate for our Injectable Drug Delivery conference please visit the hotel website
Copthorne Tara Hotel London Kensington | Hotel Kensington High Street and enter the code SMIA090523 into the promo box found on the right hand side of the page.
Please note that the preferential group rate for this event is only applicable to Superior Rooms, and therefore, this code will not work for other room types.
If you require an alternative room and further assistance, please contact Groups Tara
groups.tara@millenniumhotels.com.
The promo code and above link can only be used up to 30 days prior to the start of the conference (Monday 10th April 2023). For bookings post 10th April 2023 the preferential group rate cannot be guaranteed, and rooms are subject to availability.
